2.8 C
Saturday, February 4, 2023
- Advertisement -spot_img



Checkmate (NASDAQ: CMPI) Announces its Acquisition by Regeneron

Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) disclosed that it has inked a definitive agreement for the purchase of Checkmate...

Regeneron (NASDAQ: REGN) Announces Dupixent Earns Approval from European Commission

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NASDAQ: SNY) have confirmed that European Commission has extended the marketing authorization for Dupixent (dupilumab) in the...

Sanofi’s (NASDAQ: SNY) Dupixent (dupilumab) Receive Green Signal from CHMP

Sanofi (NASDAQ: SNY) and Regeneron (NASDAQ: REGN) have jointly created Dupilumab under a global collaboration agreement. The European Medicines Agency's Committee for Medicinal Products...

Regeneron (NASDAQ: REGN) Announces Promising Results from Dupixent Phase III Study

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Sanofi (NASDAQ: SNY) revealed the findings of the Phase III trial evaluating the effectiveness of Dupixent in babies and...

Regeneron (NASDAQ: REGN) And Sanofi’s Dupixent Accepted For Review By FDA

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NASDAQ: SNY) revealed on Thursday that FDA has awarded the authorization to Dupixent as an add-on cure...

Regeneron (NASDAQ: REGN) To Deliver Antibody Drug To Czech Ahead Of EU Registration

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is preparing to deliver 12, 000 antibody treatment to the Czech Republic before the authorization of the EU. The...

Latest news

- Advertisement -spot_img